PRECISION BIOSCIENCES INC — Director's Dealing 2021

Jun 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-06-11

Reporting Person: THOMSON DAVID S. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-11	Common Stock	M	30000	$1.18	Acquired	141513	Direct
2021-06-11	Common Stock	S	30000	$11.52	Disposed	111513	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-11	Employee Stock Option (Right to Buy)	$1.18	M	30000	Disposed	2027-06-29	Common Stock (30000)	Direct

Footnotes

F1: Includes 2,270 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 25, 2021.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $11.68. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The option is fully vested and exercisable.